Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 2,310.00
+30.00 (1.32%)
Feb 21, 2025, 4:35 PM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 5.12 billion as of February 21, 2025. Its market cap has increased by 18.24% in one year.
Market Cap
5.12B
Enterprise Value
5.94B
Revenue
2.39B
Ranking
n/a
PE Ratio
22.95
Stock Price
2,310.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 5.12B, an increase of 990.71%. That is a compound annual growth rate of 13.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |
| Genus | 1.15B |